Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Chemotherapy Infusion Pumps Market Revenue Growth On Track For A 6% CAGR Through 2030#_x000D_
The market for chemotherapy infusion pumps has experienced robust growth in recent years. This sector is anticipated to expand from $5.2 billion in 2025 to $5.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.0%. Historically, this growth can be attributed to factors such as the increasing global incidence of cancer, the rising use of chemotherapy as a primary treatment, the expansion of oncology treatment centers, the growing adoption of infusion-based drug delivery, and enhancements in infusion pump safety standards._x000D_
_x000D_
The chemotherapy infusion pumps market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $6.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period can be ascribed to factors such as a greater move towards outpatient cancer treatment, an increasing demand for oncology care provided at home, a heightened focus on shortening hospital stays, the rising implementation of personalized chemotherapy regimens, and enhanced access to cancer treatment in emerging markets. Noteworthy trends expected in this period encompass the increasing adoption of ambulatory and home-based chemotherapy delivery, a surging need for precise and controlled drug administration, a growing preference for disposable infusion pump systems, the widening use of continuous chemotherapy infusion protocols, and an increased emphasis on patient comfort and adherence to treatment._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Chemotherapy Infusion Pumps Market Expansion Drivers: What’s Shaping Future Growth?#_x000D_
The rising occurrence of cancer is anticipated to drive the expansion of the chemotherapy infusion pumps market in the future. Cancer is defined as a range of diseases characterized by the uncontrolled proliferation and spread of abnormal cells throughout the body. This condition is influenced by factors such as lifestyle modifications, inherent genetic predispositions, and a combination of genetic mutations and environmental elements like smoking, radiation, chemicals, and infectious agents. Chemotherapy infusion pumps assist cancer patients by providing precise, continuous doses of chemotherapy drugs, thereby optimizing their administration and reducing side effects. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected over 35 million new cancer cases in 2050, representing a 77% increase from the estimated 20 million cases in 2022. Thus, the increasing incidence of cancer will propel the chemotherapy infusion pumps market._x000D_
_x000D_
#Chemotherapy Infusion Pumps Market Segment Landscape And Growth Outlook#_x000D_
The chemotherapy infusion pumps market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Large Volume Pumps, Syringe Pump, Elastomeric Pumps, Ambulatory Infusion Pumps, Other Types_x000D_
2) By Usage: Disposable, Reusable_x000D_
3) By End User: Hospitals, Clinics, Home Care, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Large Volume Pumps: Traditional Large Volume Pumps, Volumetric Infusion Pumps _x000D_
2) By Syringe Pump: Manual Syringe Pumps, Electronic Syringe Pumps _x000D_
3) By Elastomeric Pumps: Disposable Elastomeric Pumps, Reusable Elastomeric Pumps _x000D_
4) By Ambulatory Infusion Pumps: Disposable Ambulatory Infusion Pumps, Reusable Ambulatory Infusion Pumps_x000D_
5) By Other Types: Smart Infusion Pumps, Patient-Controlled Analgesia (Pca) Pumps_x000D_
_x000D_
_x000D_
#Chemotherapy Infusion Pumps Market Strategic Trends: What Defines The Next Growth Phase?#_x000D_
Major companies operating in the chemotherapy infusion pumps market are introducing advanced technologies, such as adjustable infusion rates for various chemotherapy drugs, to enable more personalized and precise treatment plans. These flexible infusion rates for chemotherapy infusion pumps allow healthcare providers to modify the speed and dosage of chemotherapy drug delivery according to each patient’s unique requirements. For instance, in May 2023, Mindray, a China-based medical device and solution provider, launched an innovative infusion mode called ‘Rhythm Dose’ within their latest BeneFusion i/u infusion pump series. This sophisticated feature is specifically designed to optimize the delivery of chemotherapy drugs. It enables healthcare professionals to administer continuous intravenous infusions of multiple chemotherapy drugs at varying rates, thereby supporting more personalized treatment plans._x000D_
_x000D_
#Chemotherapy Infusion Pumps Market Competitive Overview And Top Companies#_x000D_
Major companies operating in the chemotherapy infusion pumps market are Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Medtronic plc, Smiths Medical, Terumo Corporation, Moog Inc., Nipro Corporation, Micrel Medical Devices SA, Zyno Medical LLC, Mindray Medical International Limited, Insulet Corporation, Tandem Diabetes Care Inc., CME Medical, Eitan Medical, Codan Medizinische Geräte GmbH & Co KG, SOOIL Development Co Ltd, Q‑Core Medical Ltd. _x000D_
_x000D_
#View The Full Chemotherapy Infusion Pumps Market Report:#_x000D_
_x000D_
#Chemotherapy Infusion Pumps Market Top Region: Where Does Most Revenue Come From?#_x000D_
North America was the largest region in the chemotherapy infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.